NEW YORK, March 6, 2015 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE
ACQUIRED COMMON STOCK OF PHARMACYCLICS INC. PRIOR TO
MARCH 4, 2015 AND CONTINUE
TO HOLD SUCH SHARES.
YOU ARE HEREBY NOTIFIED that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Pharmacyclics Inc. ("Pharmacyclics") (Nasdaq:
PCYC). Click here to learn more about the action:
http://zlk.9nl.com/pharmacyclics-pcyc. There is no
cost or obligation to you.
The Board of Directors of Pharmacyclics agreed to sell the
company to AbbVie (NYSE: ABBV). Under the terms of the
transaction, Pharmacyclics shareholders will receive $261.25 per share in cash and stock. The
investigation concerns whether the Board of Pharmacyclics
breached their fiduciary duties to stockholders by failing to
adequately shop the Company before agreeing to enter into this
transaction, and whether AbbVie is underpaying for Pharmacyclics
shares.
If you own Pharmacyclics common stock and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972, or visit
http://zlk.9nl.com/pharmacyclics-pcyc.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-notifies-shareholders-of-pharmacyclics-inc-of-commencement-of-class-action-investigation-concerning-the-fairness-of-the-sale-of-the-company-to-abbvie----pcyc-300046710.html
SOURCE Levi & Korsinsky, LLP